Mechanism
A peptide fragment released by stretched cardiomyocytes — measured to diagnose and monitor heart failure.
TechnicalCleavage product of proBNP; elevated in volume/pressure overload. Validated cutoffs differ by species.
Reported uses by species
| Species | Indication | Tier | Honest evidence note |
|---|---|---|---|
| Dogs & Cats | Diagnose/monitor CHF; differentiate cardiac vs respiratory dyspnea | Standard-of-care | Validated; fast in-clinic assays available. |
Suggested starting protocol
Starting points only — clinical judgment required. Dosing unlocks for verified veterinary accounts.
No species-specific starting protocol published. Contact clinical support.
Monitoring, contraindications & do-not-use-if
Diagnostic only — not a therapeutic. Interpret in clinical context.
The evidence
- de Lima & Ferreira, Veterinary World 2017